Funding Agency

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Transition Award (R00)
Project #
5R00HS022189-05
Application #
9313800
Study Section
Special Emphasis Panel (NSS)
Program Officer
Willis, Tamara
Project Start
2015-08-01
Project End
2019-01-31
Budget Start
2017-08-01
Budget End
2019-01-31
Support Year
5
Fiscal Year
2017
Total Cost
Indirect Cost

  Institution

Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705

  Publications

Harowicz, Michael R; Robinson, Timothy J; Dinan, Michaela A et al. (2017) Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset. Breast Cancer Res Treat 162:1-10
Roberts, Megan C; Bryson, Amy; Weinberger, Morris et al. (2016) ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY. Int J Technol Assess Health Care 32:355-361
Roberts, Megan C; Weinberger, Morris; Dusetzina, Stacie B et al. (2016) Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer. J Clin Oncol 34:130-8
Roberts, Megan C; Bryson, Amy; Weinberger, Morris et al. (2016) Patient-Centered Communication for Discussing Oncotype DX Testing. Cancer Invest 34:205-12
Dinan, Michaela A; Mi, Xiaojuan; Reed, Shelby D et al. (2015) Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009. JAMA Oncol 1:1098-109
Roberts, Megan C; Weinberger, Morris; Dusetzina, Stacie B et al. (2015) Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing. Breast Cancer Res Treat 153:191-200